Marlow cooks up another massive drugs deal
Ben Marlow's comment column in today's The Daily Telegraph caught my eye this morning. Not only is it a well written piece of prose but it also contains a story I myself had been chasing for the last month or so.
Ben's comment column - click on the link http://www.telegraph.co.uk/finance/11564744/If-its-Astra-bid-was-crazy-is-Pfizer-plotting-something-even-more-bonkers.html - appears to suggest US pharmaceutical giant Pfizer is plotting a multi-billion bid for GlaxoSmithKline.
Now, I had been hearing similar rumours over the last few weeks about GlaxoSmithKline but have little to back up the speculation, so decided against publishing anything.
Whilst the gossip I had picked up suggested a corporate from the US was studying GlaxoSmithKline, I had also heard that there was interest in the FTSE 100 giant from the European continent.
Clearly, Ben reckons there is something in it, so has written an incisive column on the prospects of a takeover bid for GlaxoSmithKline from Pfizer.
Given Marlow's got form in breaking massive drug deals - last year whilst working at The Sunday Times he got the scoop of 2014 with his exclusive story about Pfizer weighing a £65 billion takeover bid for AstraZeneca - I wouldn't dismiss his column as just standard market "speculation"...